KinBio is a rapidly expanding biopharmaceutical firm located in Rehovot, Israel, with a primary focus on developing necessary treatments and providing a broad range of CDMO services – from conception to product. The main emphasis of KinBio is to pursue opportunities in the global pharmaceutical market. Enhanced by a worldwide network of associated firms, Kinbio specializes in exploration, advancement, production, and commercialization of biopharmaceutical goods. Kinbio’s dedication to highest standard quality is inherent throughout the entire international organization, from our FDA sanctioned cGMP facilities to our cutting-edge R&D laboratories.